Page 10 - Eng Eong News Today

2 recents variants causing concern are those first seen in Britain and South Africa.. Read more at straitstimes.com.

ST Podcasts of the week (Jan 18) Health Check Ep 52: Addressing Covid-19 vaccine safety with Prof Ooi Eng Eong (featuring Prof Ooi Eng Eong from the Duke-NUS Medical School) Asian Insider Ep 56: Trump’s presidency - how Asia will view his legacy (featuring Professor Kishore Mahbubani, Distinguished Fellow at the Asia Research Institute at NUS, Professor C Raja Mohan from NUS Institute of South Asian Studies & Mr Ankit Panda from the Carnegie Endowment for International Peace) Lunch With S...

20:14 mins Synopsis: This is a fortnightly podcast series on Wednesdays by The Straits Times and this episode is on the safety of Covid-19 vaccines. Much has been said about the safety and effectiveness of the Covid-19 vaccine frontrunners but there are still many people who are hesitant about taking the vaccine, mostly because they are unsure if it is truly safe. Our special guest is Prof Ooi Eng Eong from the Duke-NUS Medical School. Hes the school’s principal investigator in the partnershi...

January 03, 2021 Professor Ooi Eng Eong said current control measures should suffice as the UK variant is still mainly spread through respiratory droplets. The Straits Times SINGAPORE - Measures for containing the spread of Covid-19 would still hold for the fast-spreading strain circulating in the United Kingdom which may show up in more cases here, unless it gets loose in the community, said infectious disease experts. So far there is one confirmed case with the more contagious B117 strain in ...

Professor Ooi Eng Eong said current control measures should suffice as the UK variant is still mainly spread through respiratory droplets. - The Straits Times/Asian News Network SINGAPORE, Jan 2 (The Straits Times/ANN): Measures for containing the spread of Covid-19 would still hold for the fast-spreading strain circulating in the United Kingdom which may show up in more cases here, unless it gets loose in the community, said infectious disease experts. So far there is one confi...

The Straits Times Practices like mask wearing should suffice as strain is still spread mainly via droplets Singapore has instituted travel restrictions against Britain, forbidding all long-term pass holders and short-term visitors who have been there within the last 14 days from entering or transiting through Singapore. From Monday, the same curbs will apply to travellers from South Africa, where another potentially more contagious strain is circulating. ST PHOTO: LIM YAOHUI https://str.sg/JDZc...

President Xi has pledged to make the countrys vaccines a global public good  Chinas vaccine candidates are being considered by many developing countries  China approved its first Covid-19 vaccine for general public use, developed by state-owned drug maker Sinopharm.   The pharmaceutical giant announced on Thursday that the vaccine, which is said to be 79 per cent effective, had been approved. ADVERTISEMENT The efficacy rate is based on interim analysis of Phase III clinical trials of the d...

China approves its first Covid vaccine – developed by state-owned drug company State-owned drug maker Sinopharm announced the breakthrough on Thursday with the vaccine said to be 79% effective, based on interim analysis of Phase III clinical trials . China has approved a Covid-19 vaccine by Sinopharm (Image: REUTERS) The Daily Stars FREE newsletter is spectacular! Sign up today for the best stories straight to your inboxInvalid EmailSomething went wrong, please try again later. Sign up tod...

Investors obviously considered these to be underwhelming, however.

SHARE The company making a Covid-19 vaccine with China’s state-owned manufacturer Sinopharm, said on Wednesday that its shot is 79.34 per cent effective and they are seeking to get approval to start distributing the first coronavirus drug in China. The vaccine is already being used in several countries as global Phase 3 trials continue. As different trials progress, fragmentary efficiency data have been released, but this is the first indication from the company behind the drug. The efficacy...